| Literature DB >> 30098592 |
Ji-Yeon Shin1, Kui Son Choi2,3, Mina Suh3, Boyoung Park3,4, Jae Kwan Jun5,6.
Abstract
BACKGROUND: Cervical cancer screening is not recommended for women who underwent hysterectomy with no history of cervical intraepithelial neoplasia (CIN) of grade 2 or higher. We aimed to determine the cervical cancer screening rate in Korean women who underwent hysterectomies and compare it to that in women with intact uteri.Entities:
Keywords: Guideline; Hysterectomy; Mass screening; Papanicolaou test; Uterine cervical neoplasms
Mesh:
Year: 2018 PMID: 30098592 PMCID: PMC6087535 DOI: 10.1186/s12885-018-4723-9
Source DB: PubMed Journal: BMC Cancer ISSN: 1471-2407 Impact factor: 4.430
Cervical cancer screening guidelines for women who have undergone a hysterectomy
| Guideline | Year | Recommendation | Ref. |
|---|---|---|---|
| ASCCP/ACS/ASCP | 2012 | Women at any age following a hysterectomy with removal of the cervix who have no history of CIN2+ should not be screened for vaginal cancer using any modality. | [ |
| USPSTF | 2012 | There is convincing evidence that continued screening after hysterectomy with removal of the cervix for indications other than a high-grade precancerous lesion or cervical cancer provides no benefits. | [ |
| NCCN | 2010 | Women who have had a total hysterectomy for benign indications and have no prior history of high-grade CIN should discontinue routine cytology testing. | [ |
| KSGO | 2012 | Women who have undergone hysterectomy should continue with screening tests if they have a history of CIN grade 2 or higher or if they do not know their pervious cytology results. | [ |
| NCSP | 2015 | Cervical cancer screening was not recommended for women who underwent hysterectomy and women with no history of CIN grade 2 or higher. | [ |
ASCCP American Society for Colposcopy and Cervical Pathology, ACS American Cancer Society, ASCP American Society for Clinical Pathology, USPSTF U.S Preventive Services Task Force, NCCN National Comprehensive Cancer Network, KSGO Korean Society of Gynecologic Oncology, NCSP National Cancer Screening Program, CIN Cervical Intraepithelial Neoplasia
General characteristics of the study population
| Characteristics | Reporting no hysterectomy | Reporting hysterectomy | |||
|---|---|---|---|---|---|
| n | Weighted % | n | Weighted % | ||
| Age, years | |||||
| 30–44 | 2436 | 37.2 | 18 | 7.2 | < 0.001 |
| 45–64 | 3392 | 51.7 | 167 | 67.1 | |
| 65–74 | 730 | 11.1 | 64 | 25.7 | |
| Residence area | |||||
| Metropolitan | 3003 | 45.8 | 122 | 49.0 | 0.335 |
| Urban | 3036 | 46.3 | 113 | 45.4 | |
| Rural | 519 | 7.9 | 14 | 5.6 | |
| Education, years | |||||
| ≤ 11 | 897 | 13.7 | 68 | 27.3 | < 0.001 |
| ≥ 12 | 5661 | 86.3 | 181 | 72.7 | |
| Family history of cancer | |||||
| Yes | 887 | 13.5 | 80 | 32.1 | < 0.001 |
| No | 5671 | 86.5 | 169 | 67.9 | |
| Health insurances status | |||||
| NHI | 6480 | 98.8 | 236 | 94.8 | < 0.001 |
| MAP | 78 | 1.2 | 13 | 5.2 | |
| Private health insurance | |||||
| Yes | 5628 | 85.8 | 199 | 79.9 | 0.009 |
| No | 930 | 14.2 | 50 | 20.1 | |
| Monthly household income, USDa | |||||
| < 2500 | 1059 | 16.2 | 56 | 22.5 | 0.013 |
| 2500–4499 | 3199 | 48.8 | 103 | 41.4 | |
| ≥ 4500 | 2300 | 35.1 | 90 | 36.1 | |
| Time since most recent Pap smear test, years | |||||
| < 1 | 1985 | 30.3 | 77 | 30.9 | 0.003 |
| 1–2 | 2260 | 34.5 | 77 | 30.9 | |
| > 2 | 628 | 9.6 | 41 | 16.5 | |
| Never | 1685 | 25.7 | 54 | 21.7 | |
NHI National Health Insurance, MAP Medical Aid Program
a1 USD = 1000 KWN
Cervical cancer screening rates according to hysterectomy status and sociodemographic variables
| Characteristics | Reporting no hysterectomy | Reporting hysterectomy | Reporting hysterectomy vs. reporting no hysterectomy | |||||
|---|---|---|---|---|---|---|---|---|
| Screening rate | (95% CI) | Screening rate | (95% CI) | cOR | (95% CI) | aOR | (95% CI) | |
| Overall | 64.7 | (64.1–65.3) | 61.8 | (58.8–64.9) | 0.87 | (0.67–1.13) | 0.75 | (0.57–0.98) |
| Age, years | ||||||||
| 30–44 | 57.1 | (56.1–58.1) | 77.8 | (68.0–87.6) | 2.70 | (0.88–8.22) | 2.36 | (0.75–7.44) |
| 45–64 | 70.1 | (69.3–70.9) | 64.7 | (61.0–68.4) | 0.77 | (0.56–1.07) | 0.75 | (0.54–1.05) |
| 65–74 | 64.9 | (63.2–66.7) | 50.0 | (43.8–56.3) | 0.55 | (0.33–0.93) | 0.53 | (0.31–0.91) |
| Residence area | ||||||||
| Metropolitan | 65.8 | (64.9–66.7) | 58.2 | (53.7–62.7) | 0.72 | (0.50–1.04) | 0.59 | (0.40–0.88) |
| Urban | 64.1 | (63.3–65.0) | 66.4 | (61.9–70.8) | 1.07 | (0.72–1.60) | 0.97 | (0.65–1.46) |
| Rural | 62.0 | (59.9–64.2) | 57.1 | (43.9–70.4) | 0.83 | (0.28–2.44) | 0.75 | (0.24–2.31) |
| Education, years | ||||||||
| ≤ 11 | 67.2 | (65.7–68.8) | 64.7 | (58.9–70.5) | 0.82 | (0.49–1.39) | 0.92 | (0.54–1.56) |
| ≥ 12 | 64.3 | (63.7–65.0) | 60.8 | (57.1–64.4) | 0.87 | (0.64–1.18) | 0.69 | (0.50–0.95) |
| Family history of cancer | ||||||||
| Yes | 67.1 | (65.5–68.7) | 75.0 | (70.2–79.8) | 1.47 | (0.87–2.49) | 1.42 | (0.82–2.44) |
| No | 64.4 | (63.7–65.0) | 55.6 | (51.8–59.4) | 0.69 | (0.50–0.94) | 0.59 | (0.43–0.81) |
| Health insurance status | ||||||||
| NHI | 64.8 | (64.2–65.4) | 62.7 | (59.6–65.9) | 0.90 | (0.69–1.18) | 0.75 | (0.57–0.99) |
| MAP | 57.7 | (52.1–63.3) | 46.2 | (32.3–60.0) | 0.64 | (0.19–2.15) | 0.86 | (0.19–3.90) |
| Private health insurance | ||||||||
| Yes | 66.0 | (65.4–66.7) | 62.8 | (59.4–66.2) | 0.88 | (0.65–1.17) | 0.70 | (0.52–0.95) |
| No | 56.9 | (55.3–58.5) | 58.0 | (51.0–65.0) | 0.96 | (0.54–1.73) | 1.01 | (0.55–1.85) |
| Monthly household income, USDa | ||||||||
| < 2500 | 65.3 | (63.9–66.8) | 48.2 | (41.5–54.9) | 0.48 | (0.28–0.82) | 0.49 | (0.28–0.86) |
| 2500–4499 | 61.9 | (61.0–62.7) | 63.1 | (58.4–67.9) | 1.03 | (0.69–1.55) | 0.86 | (0.57–1.31) |
| ≥ 4500 | 68.4 | (67.5–69.4) | 68.9 | (64.0–73.8) | 1.05 | (0.66–1.65) | 0.87 | (0.54–1.41) |
CI confidence intervals, cOR crude odds ratio, aOR adjusted odds ratio, Adjustments were made for age, residence area, education, family history of cancer, health insurance status, private health insurance, and monthly household income, NHI National Health Insurance, MAP Medical Aid Program
a1 USD = 1000 KWN